MEDTRONIC LIMITED
Get an alert when MEDTRONIC LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2027-01-31 (in 8mo)
Last filed for 2025-04-25
Confirmation statement due
2026-07-10 (in 2mo)
Last made up 2025-06-26
Watchouts
None on the register
Cash
£66M
-16.1% vs 2024
Net assets
£126M
-4.1% vs 2024
Employees
998
+2% vs 2024
Profit before tax
£34M
+4.7% vs 2024
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2025-04-25
| Metric | Trend | 2024-04-26 | 2025-04-25 |
|---|---|---|---|
| Turnover | £648,549,000 | £689,964,000 | |
| Operating profit | £21,926,000 | £23,994,000 | |
| Profit before tax | £32,298,000 | £33,810,000 | |
| Net profit | £25,645,000 | £26,453,000 | |
| Cash | £78,194,000 | £65,629,000 | |
| Total assets less current liabilities | £151,227,000 | £147,290,000 | |
| Net assets | £131,462,000 | £126,071,000 | |
| Equity | £131,462,000 | £126,071,000 | |
| Average employees | 978 | 998 | |
| Wages | £78,267,000 | £82,703,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-04-26 | 2025-04-25 |
|---|---|---|---|
| Operating margin | 3.4% | 3.5% | |
| Net margin | 4.0% | 3.8% | |
| Return on capital employed | 14.5% | 16.3% | |
| Gearing (liabilities / total assets) | 63.5% | 65.1% | |
| Current ratio | 1.67x | 1.64x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continuc as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.”
Significant events
- “On May 21, 2025, the parent company, Medtronic Plc, announced its intent to separate its global Diabetes business into a new standalone public company.”
- “After the end of the financial period ended 25 April 2025, it has been brought to the attention of the directors that the Company had received the benefit of net operating losses ("NOLs") transferred from another Group entity without payment of any monetary consideration (i.e. assets with an intrinsic value were transferred by the Group entity for which the Group entity was not compensated)... The total amount expected to be paid by the Company is £7,720k.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 36 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ALKIS, Pinar Burcu | Director | 2024-11-25 | Apr 1978 | Turkish |
| WILLIAMS-GRAY, Matthew Christian | Director | 2024-07-31 | Oct 1976 | British |
Show 36 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DRAKE, William Everett | Secretary | — | 1993-06-28 |
| LUND, Ronald Eugene | Secretary | 1993-03-01 | 2000-01-01 |
| MALKINSON, Carol | Secretary | 1993-03-01 | 2002-11-01 |
| MITRE SECRETARIES LIMITED | Corporate Secretary | 2002-11-01 | 2024-05-15 |
| ALBERT, Philip John | Director | 2012-11-12 | 2021-03-26 |
| BAROT, Bhavesh Bhupatsinh | Director | 2022-08-01 | 2022-12-09 |
| BEUMER, Dale Frederick | Director | 2000-10-09 | 2003-02-01 |
| BONCY, Roger Richard | Director | 1995-08-01 | 1998-04-14 |
| BROWN, Helen Louise | Director | 2016-11-01 | 2021-02-01 |
| CHORSKE, William Walter | Director | — | 1995-08-01 |
| COLLINS JR, Arthur Dunnicliffe | Director | — | 2002-01-07 |
| DOVELL, Matthew Ian | Director | 2011-09-08 | 2016-11-01 |
| ELSEY, Mark Justin | Director | 2020-12-01 | 2024-11-25 |
| ELSEY, Mark Justin | Director | 2012-02-01 | 2019-04-01 |
| ERICKSON, Davilynn Ann | Director | 2019-04-01 | 2020-12-01 |
| FIELDING, Jacqueline | Director | 2011-02-07 | 2021-01-01 |
| FLANCHON, Gerard Constant | Director | — | 1993-06-28 |
| GEORGE, William Wallace | Director | — | 1996-03-01 |
| HAMILTON, Shaundra Deneen | Director | 2009-01-07 | 2012-02-01 |
| KARSUNKY, Robert | Director | 2003-02-01 | 2004-09-10 |
| LUND, Ronald Eugene | Director | — | 2000-01-01 |
| MEERTENS, Henri Anna | Director | 2006-06-26 | 2010-07-14 |
| MERKUN, Jozef Willem | Director | — | 2003-12-22 |
| MORRIS, Geoffrey Charles | Director | 2002-01-07 | 2011-02-07 |
| MYRUM, Stanton Dean | Director | 1998-08-26 | 2001-09-08 |
| OLDAKER, Julian Charles | Director | 2021-03-26 | 2022-08-01 |
| PLEIJSIER, Arthur | Director | 2010-07-14 | 2012-11-12 |
| SCHENK, Alexander Bastiaan | Director | 2004-01-14 | 2006-06-26 |
| SCOTT, David | Director | 2000-10-19 | 2002-01-07 |
| SHARKEY, Gabriel Bernard | Director | 2004-09-10 | 2008-10-31 |
| SMITH, Mark William | Director | — | 1993-06-28 |
| TEFFT, Thomas Michael | Director | 1995-08-01 | 1999-11-17 |
| VAN ZUILEN, Wilhelmus Johannes Maria | Director | 2021-01-01 | 2021-05-28 |
| VILLANI, Jessica | Director | 2021-02-01 | 2021-03-26 |
| WADE, Briony Anne | Director | 2023-03-22 | 2024-07-31 |
| WILSON, Barry Woodrow | Director | 1995-08-01 | 1997-03-19 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Medtronic Public Limited Company | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 233 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-21 | MA | incorporation | Memorandum articles | |
| 2026-03-21 | RESOLUTIONS | resolution | Resolution | |
| 2026-02-02 | AA | accounts | Accounts with accounts type full | |
| 2026-01-12 | CH01 | officers | Change person director company with change date | |
| 2025-11-06 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2025-07-07 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-03-31 | AA | accounts | Accounts with accounts type full | |
| 2024-11-25 | AP01 | officers | Appoint person director company with name date | |
| 2024-11-25 | TM01 | officers | Termination director company with name termination date | |
| 2024-08-05 | AP01 | officers | Appoint person director company with name date | |
| 2024-08-05 | TM01 | officers | Termination director company with name termination date | |
| 2024-06-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-05-23 | TM02 | officers | Termination secretary company with name termination date | |
| 2024-02-07 | AA | accounts | Accounts with accounts type full | |
| 2023-07-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-06-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-04-03 | AAMD | accounts | Accounts amended with accounts type full | |
| 2023-03-22 | AP01 | officers | Appoint person director company with name date | |
| 2022-12-19 | AA | accounts | Accounts with accounts type full | |
| 2022-12-12 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2024 → FY2025 · period ending 2025-04-25 vs 2024-04-26
-
Turnover
+6.4%
£648,549,000 £689,964,000
-
Cash
-16.1%
£78,194,000 £65,629,000
-
Net assets
-4.1%
£131,462,000 £126,071,000
-
Employees
+2%
978 998
-
Operating profit
+9.4%
£21,926,000 £23,994,000
-
Profit before tax
+4.7%
£32,298,000 £33,810,000
-
Wages
+5.7%
£78,267,000 £82,703,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers